LGALS3 and neuroendocrine neoplasm: Galectin-3 overexpression is associated with the increased invasiveness of many types of tumor cells, including neuroendocrine tumor pheochromocytoma, ovarian, melanoma, thyroid, and colorectal cancer cells [28, 35].